Loading…
Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients
DTC accounts for the majority of endocrine tumors. While the incidence of thyroid cancer has been increasing globally over the past few decades, papillary thyroid carcinoma (PTC) generally shows an excellent prognosis, except in cases with aggressive clinicopathological features. This study aimed to...
Saved in:
Published in: | Cancers 2023-08, Vol.15 (16), p.4102 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c466t-b938ee78d3807e90ef440c6d7a46d7aad3f63a1da9bb730c133c48273f81315c3 |
---|---|
cites | cdi_FETCH-LOGICAL-c466t-b938ee78d3807e90ef440c6d7a46d7aad3f63a1da9bb730c133c48273f81315c3 |
container_end_page | |
container_issue | 16 |
container_start_page | 4102 |
container_title | Cancers |
container_volume | 15 |
creator | Al-Ibraheem, Akram Al-Rasheed, Ula Mashhadani, Noor Abdlkadir, Ahmed Saad Al-Adhami, Dhuha Ali Ruzzeh, Saad Istatieh, Feras Mansour, Areen Hamdan, Basem Kheetan, Reem Al-Shatti, Marwa Mohamad, Issa Juweid, Malik E Abu Sheikha, Areej Al-Rabi, Kamal Sykiotis, Gerasimos P Kreissl, Michael C Ismael, Taleb Sultan, Iyad Abdel-Razeq, Hikmat |
description | DTC accounts for the majority of endocrine tumors. While the incidence of thyroid cancer has been increasing globally over the past few decades, papillary thyroid carcinoma (PTC) generally shows an excellent prognosis, except in cases with aggressive clinicopathological features. This study aimed to assess the 5- and 10-year overall survival (OS) and progression-free survival (PFS) of 528 Arabic patients diagnosed with primary DTC from 1998 to 2021. Additionally, the study aimed to analyze the impact of various factors on both OS and PFS. An univariable survival analysis was conducted using Kaplan–Meier curves. The 5- and 10-year OS for patients with DTC have exceeded 95%. Additionally, PFS showed very good rates (ranging between 96.5 and 85% at 5 and 10 years, respectively). Age, male gender, risk of recurrence, and distant metastasis were identified as the main negative prognostic factors for both OS and PFS, while RAI treatment was found to be a significant factor in improving OS. Moreover, adherence to the King Hussein Cancer Center’s (KHCC) CPG demonstrated significant improvement in PFS. These findings highlight common prognostic factors and favorable outcomes in Arabic patients with DTC treated at a tertiary cancer center using standard of care approaches. |
doi_str_mv | 10.3390/cancers15164102 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10452119</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A762474423</galeid><sourcerecordid>A762474423</sourcerecordid><originalsourceid>FETCH-LOGICAL-c466t-b938ee78d3807e90ef440c6d7a46d7aad3f63a1da9bb730c133c48273f81315c3</originalsourceid><addsrcrecordid>eNptUk1v3CAQtapWTZTm3CtSL-nBCV8Gu5dq5TbdKCslUraHnhDG2EtkQwrY1f7F_qriJlo1UUFiYHjvzQxMlr1H8JyQCl4oaZX2ARWIUQTxq-wYQ45zxir6-p_9UXYawj1MgxDEGX-bHRHOMEcEHme_N872-Vb7EdxNfjazHMDKymEfTADStuDWu966EI0Cl1JF5wNwHVh52STPrYxG2xjALxN34IvpOu3T2cioW7Dd7b0zLailV8a6UX4CK4Bh_kNLD26aoP2c6C4FA3dxavdARhB3Glwb24P1FII2NpGXGkGdVJM5u17X9UdwZWc3zAuswOUhiXfZm04OQZ8-2ZPs--XXbb3ONzffrurVJleUsZg3FSm15mVLSsh1BXVHKVSs5ZIui2xJx4hErayahhOoECGKlpiTrkQEFYqcZJ8fdR-mZtStSrG9HMSDN6P0e-GkEc9vrNmJ3s0CQVpghKqkcPak4N3PSYcoRhOUHgZptZuCwGXBS1oUeIF-eAG9d5NPb_YXxaqC8ZTaAdXLQQtjO5cCq0VUrNJXU04pJgl1_h9Umq0ejXJWdyb5nxEuHgnKuxC87g5FIiiWFhQvWpD8AVw5zwA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2856956727</pqid></control><display><type>article</type><title>Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><creator>Al-Ibraheem, Akram ; Al-Rasheed, Ula ; Mashhadani, Noor ; Abdlkadir, Ahmed Saad ; Al-Adhami, Dhuha Ali ; Ruzzeh, Saad ; Istatieh, Feras ; Mansour, Areen ; Hamdan, Basem ; Kheetan, Reem ; Al-Shatti, Marwa ; Mohamad, Issa ; Juweid, Malik E ; Abu Sheikha, Areej ; Al-Rabi, Kamal ; Sykiotis, Gerasimos P ; Kreissl, Michael C ; Ismael, Taleb ; Sultan, Iyad ; Abdel-Razeq, Hikmat</creator><creatorcontrib>Al-Ibraheem, Akram ; Al-Rasheed, Ula ; Mashhadani, Noor ; Abdlkadir, Ahmed Saad ; Al-Adhami, Dhuha Ali ; Ruzzeh, Saad ; Istatieh, Feras ; Mansour, Areen ; Hamdan, Basem ; Kheetan, Reem ; Al-Shatti, Marwa ; Mohamad, Issa ; Juweid, Malik E ; Abu Sheikha, Areej ; Al-Rabi, Kamal ; Sykiotis, Gerasimos P ; Kreissl, Michael C ; Ismael, Taleb ; Sultan, Iyad ; Abdel-Razeq, Hikmat</creatorcontrib><description>DTC accounts for the majority of endocrine tumors. While the incidence of thyroid cancer has been increasing globally over the past few decades, papillary thyroid carcinoma (PTC) generally shows an excellent prognosis, except in cases with aggressive clinicopathological features. This study aimed to assess the 5- and 10-year overall survival (OS) and progression-free survival (PFS) of 528 Arabic patients diagnosed with primary DTC from 1998 to 2021. Additionally, the study aimed to analyze the impact of various factors on both OS and PFS. An univariable survival analysis was conducted using Kaplan–Meier curves. The 5- and 10-year OS for patients with DTC have exceeded 95%. Additionally, PFS showed very good rates (ranging between 96.5 and 85% at 5 and 10 years, respectively). Age, male gender, risk of recurrence, and distant metastasis were identified as the main negative prognostic factors for both OS and PFS, while RAI treatment was found to be a significant factor in improving OS. Moreover, adherence to the King Hussein Cancer Center’s (KHCC) CPG demonstrated significant improvement in PFS. These findings highlight common prognostic factors and favorable outcomes in Arabic patients with DTC treated at a tertiary cancer center using standard of care approaches.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers15164102</identifier><identifier>PMID: 37627130</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Analysis ; Cancer ; Cancer therapies ; Carcinoma ; Development and progression ; Disease control ; Gender ; Geographical variations ; Iodine ; Lymphatic system ; Males ; Medical prognosis ; Medical records ; Metastases ; Metastasis ; Mortality ; Neck ; Observational studies ; Oncology ; Oncology, Experimental ; Papillary thyroid carcinoma ; Patient outcomes ; Patients ; Population studies ; Prognosis ; Radiation ; Survival ; Survival analysis ; Thyroid cancer ; Thyroidectomy ; Tomography ; Tumors ; Ultrasonic imaging</subject><ispartof>Cancers, 2023-08, Vol.15 (16), p.4102</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c466t-b938ee78d3807e90ef440c6d7a46d7aad3f63a1da9bb730c133c48273f81315c3</citedby><cites>FETCH-LOGICAL-c466t-b938ee78d3807e90ef440c6d7a46d7aad3f63a1da9bb730c133c48273f81315c3</cites><orcidid>0000-0001-5905-6015 ; 0000-0003-2833-6051 ; 0000-0002-2664-1565 ; 0000-0002-0978-4716 ; 0000-0003-0153-9131 ; 0000-0002-9565-4941</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2856956727/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2856956727?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids></links><search><creatorcontrib>Al-Ibraheem, Akram</creatorcontrib><creatorcontrib>Al-Rasheed, Ula</creatorcontrib><creatorcontrib>Mashhadani, Noor</creatorcontrib><creatorcontrib>Abdlkadir, Ahmed Saad</creatorcontrib><creatorcontrib>Al-Adhami, Dhuha Ali</creatorcontrib><creatorcontrib>Ruzzeh, Saad</creatorcontrib><creatorcontrib>Istatieh, Feras</creatorcontrib><creatorcontrib>Mansour, Areen</creatorcontrib><creatorcontrib>Hamdan, Basem</creatorcontrib><creatorcontrib>Kheetan, Reem</creatorcontrib><creatorcontrib>Al-Shatti, Marwa</creatorcontrib><creatorcontrib>Mohamad, Issa</creatorcontrib><creatorcontrib>Juweid, Malik E</creatorcontrib><creatorcontrib>Abu Sheikha, Areej</creatorcontrib><creatorcontrib>Al-Rabi, Kamal</creatorcontrib><creatorcontrib>Sykiotis, Gerasimos P</creatorcontrib><creatorcontrib>Kreissl, Michael C</creatorcontrib><creatorcontrib>Ismael, Taleb</creatorcontrib><creatorcontrib>Sultan, Iyad</creatorcontrib><creatorcontrib>Abdel-Razeq, Hikmat</creatorcontrib><title>Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients</title><title>Cancers</title><description>DTC accounts for the majority of endocrine tumors. While the incidence of thyroid cancer has been increasing globally over the past few decades, papillary thyroid carcinoma (PTC) generally shows an excellent prognosis, except in cases with aggressive clinicopathological features. This study aimed to assess the 5- and 10-year overall survival (OS) and progression-free survival (PFS) of 528 Arabic patients diagnosed with primary DTC from 1998 to 2021. Additionally, the study aimed to analyze the impact of various factors on both OS and PFS. An univariable survival analysis was conducted using Kaplan–Meier curves. The 5- and 10-year OS for patients with DTC have exceeded 95%. Additionally, PFS showed very good rates (ranging between 96.5 and 85% at 5 and 10 years, respectively). Age, male gender, risk of recurrence, and distant metastasis were identified as the main negative prognostic factors for both OS and PFS, while RAI treatment was found to be a significant factor in improving OS. Moreover, adherence to the King Hussein Cancer Center’s (KHCC) CPG demonstrated significant improvement in PFS. These findings highlight common prognostic factors and favorable outcomes in Arabic patients with DTC treated at a tertiary cancer center using standard of care approaches.</description><subject>Analysis</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Carcinoma</subject><subject>Development and progression</subject><subject>Disease control</subject><subject>Gender</subject><subject>Geographical variations</subject><subject>Iodine</subject><subject>Lymphatic system</subject><subject>Males</subject><subject>Medical prognosis</subject><subject>Medical records</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Mortality</subject><subject>Neck</subject><subject>Observational studies</subject><subject>Oncology</subject><subject>Oncology, Experimental</subject><subject>Papillary thyroid carcinoma</subject><subject>Patient outcomes</subject><subject>Patients</subject><subject>Population studies</subject><subject>Prognosis</subject><subject>Radiation</subject><subject>Survival</subject><subject>Survival analysis</subject><subject>Thyroid cancer</subject><subject>Thyroidectomy</subject><subject>Tomography</subject><subject>Tumors</subject><subject>Ultrasonic imaging</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptUk1v3CAQtapWTZTm3CtSL-nBCV8Gu5dq5TbdKCslUraHnhDG2EtkQwrY1f7F_qriJlo1UUFiYHjvzQxMlr1H8JyQCl4oaZX2ARWIUQTxq-wYQ45zxir6-p_9UXYawj1MgxDEGX-bHRHOMEcEHme_N872-Vb7EdxNfjazHMDKymEfTADStuDWu966EI0Cl1JF5wNwHVh52STPrYxG2xjALxN34IvpOu3T2cioW7Dd7b0zLailV8a6UX4CK4Bh_kNLD26aoP2c6C4FA3dxavdARhB3Glwb24P1FII2NpGXGkGdVJM5u17X9UdwZWc3zAuswOUhiXfZm04OQZ8-2ZPs--XXbb3ONzffrurVJleUsZg3FSm15mVLSsh1BXVHKVSs5ZIui2xJx4hErayahhOoECGKlpiTrkQEFYqcZJ8fdR-mZtStSrG9HMSDN6P0e-GkEc9vrNmJ3s0CQVpghKqkcPak4N3PSYcoRhOUHgZptZuCwGXBS1oUeIF-eAG9d5NPb_YXxaqC8ZTaAdXLQQtjO5cCq0VUrNJXU04pJgl1_h9Umq0ejXJWdyb5nxEuHgnKuxC87g5FIiiWFhQvWpD8AVw5zwA</recordid><startdate>20230801</startdate><enddate>20230801</enddate><creator>Al-Ibraheem, Akram</creator><creator>Al-Rasheed, Ula</creator><creator>Mashhadani, Noor</creator><creator>Abdlkadir, Ahmed Saad</creator><creator>Al-Adhami, Dhuha Ali</creator><creator>Ruzzeh, Saad</creator><creator>Istatieh, Feras</creator><creator>Mansour, Areen</creator><creator>Hamdan, Basem</creator><creator>Kheetan, Reem</creator><creator>Al-Shatti, Marwa</creator><creator>Mohamad, Issa</creator><creator>Juweid, Malik E</creator><creator>Abu Sheikha, Areej</creator><creator>Al-Rabi, Kamal</creator><creator>Sykiotis, Gerasimos P</creator><creator>Kreissl, Michael C</creator><creator>Ismael, Taleb</creator><creator>Sultan, Iyad</creator><creator>Abdel-Razeq, Hikmat</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5905-6015</orcidid><orcidid>https://orcid.org/0000-0003-2833-6051</orcidid><orcidid>https://orcid.org/0000-0002-2664-1565</orcidid><orcidid>https://orcid.org/0000-0002-0978-4716</orcidid><orcidid>https://orcid.org/0000-0003-0153-9131</orcidid><orcidid>https://orcid.org/0000-0002-9565-4941</orcidid></search><sort><creationdate>20230801</creationdate><title>Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients</title><author>Al-Ibraheem, Akram ; Al-Rasheed, Ula ; Mashhadani, Noor ; Abdlkadir, Ahmed Saad ; Al-Adhami, Dhuha Ali ; Ruzzeh, Saad ; Istatieh, Feras ; Mansour, Areen ; Hamdan, Basem ; Kheetan, Reem ; Al-Shatti, Marwa ; Mohamad, Issa ; Juweid, Malik E ; Abu Sheikha, Areej ; Al-Rabi, Kamal ; Sykiotis, Gerasimos P ; Kreissl, Michael C ; Ismael, Taleb ; Sultan, Iyad ; Abdel-Razeq, Hikmat</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c466t-b938ee78d3807e90ef440c6d7a46d7aad3f63a1da9bb730c133c48273f81315c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Analysis</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Carcinoma</topic><topic>Development and progression</topic><topic>Disease control</topic><topic>Gender</topic><topic>Geographical variations</topic><topic>Iodine</topic><topic>Lymphatic system</topic><topic>Males</topic><topic>Medical prognosis</topic><topic>Medical records</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Mortality</topic><topic>Neck</topic><topic>Observational studies</topic><topic>Oncology</topic><topic>Oncology, Experimental</topic><topic>Papillary thyroid carcinoma</topic><topic>Patient outcomes</topic><topic>Patients</topic><topic>Population studies</topic><topic>Prognosis</topic><topic>Radiation</topic><topic>Survival</topic><topic>Survival analysis</topic><topic>Thyroid cancer</topic><topic>Thyroidectomy</topic><topic>Tomography</topic><topic>Tumors</topic><topic>Ultrasonic imaging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Al-Ibraheem, Akram</creatorcontrib><creatorcontrib>Al-Rasheed, Ula</creatorcontrib><creatorcontrib>Mashhadani, Noor</creatorcontrib><creatorcontrib>Abdlkadir, Ahmed Saad</creatorcontrib><creatorcontrib>Al-Adhami, Dhuha Ali</creatorcontrib><creatorcontrib>Ruzzeh, Saad</creatorcontrib><creatorcontrib>Istatieh, Feras</creatorcontrib><creatorcontrib>Mansour, Areen</creatorcontrib><creatorcontrib>Hamdan, Basem</creatorcontrib><creatorcontrib>Kheetan, Reem</creatorcontrib><creatorcontrib>Al-Shatti, Marwa</creatorcontrib><creatorcontrib>Mohamad, Issa</creatorcontrib><creatorcontrib>Juweid, Malik E</creatorcontrib><creatorcontrib>Abu Sheikha, Areej</creatorcontrib><creatorcontrib>Al-Rabi, Kamal</creatorcontrib><creatorcontrib>Sykiotis, Gerasimos P</creatorcontrib><creatorcontrib>Kreissl, Michael C</creatorcontrib><creatorcontrib>Ismael, Taleb</creatorcontrib><creatorcontrib>Sultan, Iyad</creatorcontrib><creatorcontrib>Abdel-Razeq, Hikmat</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Al-Ibraheem, Akram</au><au>Al-Rasheed, Ula</au><au>Mashhadani, Noor</au><au>Abdlkadir, Ahmed Saad</au><au>Al-Adhami, Dhuha Ali</au><au>Ruzzeh, Saad</au><au>Istatieh, Feras</au><au>Mansour, Areen</au><au>Hamdan, Basem</au><au>Kheetan, Reem</au><au>Al-Shatti, Marwa</au><au>Mohamad, Issa</au><au>Juweid, Malik E</au><au>Abu Sheikha, Areej</au><au>Al-Rabi, Kamal</au><au>Sykiotis, Gerasimos P</au><au>Kreissl, Michael C</au><au>Ismael, Taleb</au><au>Sultan, Iyad</au><au>Abdel-Razeq, Hikmat</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients</atitle><jtitle>Cancers</jtitle><date>2023-08-01</date><risdate>2023</risdate><volume>15</volume><issue>16</issue><spage>4102</spage><pages>4102-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>DTC accounts for the majority of endocrine tumors. While the incidence of thyroid cancer has been increasing globally over the past few decades, papillary thyroid carcinoma (PTC) generally shows an excellent prognosis, except in cases with aggressive clinicopathological features. This study aimed to assess the 5- and 10-year overall survival (OS) and progression-free survival (PFS) of 528 Arabic patients diagnosed with primary DTC from 1998 to 2021. Additionally, the study aimed to analyze the impact of various factors on both OS and PFS. An univariable survival analysis was conducted using Kaplan–Meier curves. The 5- and 10-year OS for patients with DTC have exceeded 95%. Additionally, PFS showed very good rates (ranging between 96.5 and 85% at 5 and 10 years, respectively). Age, male gender, risk of recurrence, and distant metastasis were identified as the main negative prognostic factors for both OS and PFS, while RAI treatment was found to be a significant factor in improving OS. Moreover, adherence to the King Hussein Cancer Center’s (KHCC) CPG demonstrated significant improvement in PFS. These findings highlight common prognostic factors and favorable outcomes in Arabic patients with DTC treated at a tertiary cancer center using standard of care approaches.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>37627130</pmid><doi>10.3390/cancers15164102</doi><orcidid>https://orcid.org/0000-0001-5905-6015</orcidid><orcidid>https://orcid.org/0000-0003-2833-6051</orcidid><orcidid>https://orcid.org/0000-0002-2664-1565</orcidid><orcidid>https://orcid.org/0000-0002-0978-4716</orcidid><orcidid>https://orcid.org/0000-0003-0153-9131</orcidid><orcidid>https://orcid.org/0000-0002-9565-4941</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2072-6694 |
ispartof | Cancers, 2023-08, Vol.15 (16), p.4102 |
issn | 2072-6694 2072-6694 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10452119 |
source | Open Access: PubMed Central; Publicly Available Content Database |
subjects | Analysis Cancer Cancer therapies Carcinoma Development and progression Disease control Gender Geographical variations Iodine Lymphatic system Males Medical prognosis Medical records Metastases Metastasis Mortality Neck Observational studies Oncology Oncology, Experimental Papillary thyroid carcinoma Patient outcomes Patients Population studies Prognosis Radiation Survival Survival analysis Thyroid cancer Thyroidectomy Tomography Tumors Ultrasonic imaging |
title | Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T17%3A38%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-Term%20Survival%20Analysis%20and%20Prognostic%20Factors%20of%20Arabic%20Patients%20with%20Differentiated%20Thyroid%20Carcinoma:%20A%2020-Year%20Observational%20Study%20at%20the%20King%20Hussein%20Cancer%20Center%20(KHCC)%20Involving%20528%20Patients&rft.jtitle=Cancers&rft.au=Al-Ibraheem,%20Akram&rft.date=2023-08-01&rft.volume=15&rft.issue=16&rft.spage=4102&rft.pages=4102-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers15164102&rft_dat=%3Cgale_pubme%3EA762474423%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c466t-b938ee78d3807e90ef440c6d7a46d7aad3f63a1da9bb730c133c48273f81315c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2856956727&rft_id=info:pmid/37627130&rft_galeid=A762474423&rfr_iscdi=true |